ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 20

Complement Deposition On Platelets Is Associated To Venous Thrombosis In Systemic Lupus Erythematosus

Christian Lood1, Helena Tydén1, Birgitta Gullstrand2, Gunnar Sturfelt3, Andreas Jönsen1, Lennart Truedsson2 and Anders A. Bengtsson1, 1Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden, 2Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden, 3Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Sweden

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, complement, platelets and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Antiphospholipid Syndrome: Clinical Manifestations and New Biomarkers in Antiphospholipid Syndrome

Session Type: Abstract Submissions (ACR)

Background/Purpose: Anti-phospholipid (aPL) antibodies are associated with development of venous thrombosis and stroke in the autoimmune disease systemic lupus erythematosus (SLE). The underlying mechanism for aPL-mediated thrombosis is not known but may include activation of platelets and the complement system. The aim of this study was to investigate if aPL antibodies could interact with platelets and support complement activation. Furthermore, we investigated if this mechanism was operating in SLE patients and whether complement deposition on platelets was associated to venous thrombosis and specific for SLE.

Methods: Complement deposition was measured by flow cytometry in patients with SLE, rheumatoid arthritis, systemic sclerosis, myocardial infarction and healthy individuals. Associations to cardiovascular disease were analyzed with logistic regression analysis and adjusted for traditional risk factors. Anti-cardiolipin antibodies were used to investigate if aPL antibodies supported platelet activation and complement deposition.

Results: Platelet deposition of C1q and C4d was increased in SLE as compared to healthy individuals (p<0.0001), but high levels were also seen in some patients with rheumatoid arthritis and systemic sclerosis. Complement deposition was clearly associated to venous thrombosis and aPL antibodies in SLE. In vitro, anti-cardiolipin antibodies increased platelet activation and supported C4d deposition on platelets.

Conclusion: Platelet C1q and C4d deposition are identified as markers of venous thrombosis in SLE patients. Several mechanisms are operating in SLE to amplify platelet complement deposition, of which anti-cardiolipin antibodies was identified as one important contributor. Further studies are needed to elucidate the role of platelet complement deposition in development of venous thrombosis.


Disclosure:

C. Lood,
None;

H. Tydén,
None;

B. Gullstrand,
None;

G. Sturfelt,
None;

A. Jönsen,
None;

L. Truedsson,
None;

A. A. Bengtsson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/complement-deposition-on-platelets-is-associated-to-venous-thrombosis-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology